The estimated Net Worth of Philippe Deschamps is at least $12.8 Thousand dollars as of 5 April 2019. Philippe Deschamps owns over 5,018 units of Helius Medical Technologies Inc stock worth over $12,796 and over the last 9 years Philippe sold HSDT stock worth over $0.
Sign up
Philippe Deschamps HSDT stock SEC Form 4 insiders trading
Philippe has made over 2 trades of the Helius Medical Technologies Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Philippe exercised 5,018 units of HSDT stock worth $28,101 on 5 April 2019.
The largest trade Philippe's ever made was buying 127,551 units of Helius Medical Technologies Inc stock on 22 December 2017 worth over $250,000. On average, Philippe trades about 7,365 units every 26 days since 2016. As of 5 April 2019 Philippe still owns at least 15,995 units of Helius Medical Technologies Inc stock.
You can see the complete history of Philippe Deschamps stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Philippe Deschamps's mailing address?
Philippe's mailing address filed with the SEC is 642 NEWTOWN-YARDLEY ROAD, SUITE 100, NEWTOWN, PA, 18940.
Insiders trading at Helius Medical Technologies Inc
Over the last 9 years, insiders at Helius Medical Technologies Inc have traded over $0 worth of Helius Medical Technologies Inc stock and bought 1,827,117 units worth $3,547,767 . The most active insiders traders include Dane Andreeff, Blane Walter, and Philippe Deschamps. On average, Helius Medical Technologies Inc executives and independent directors trade stock every 121 days with the average trade being worth of $58,628. The most recent stock trade was executed by Dane Andreeff on 14 December 2023, trading 5,000 units of HSDT stock currently worth $40,500.
What does Helius Medical Technologies Inc do?
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
What does Helius Medical Technologies Inc's logo look like?
Complete history of Philippe Deschamps stock trades at Helius Medical Technologies Inc
Helius Medical Technologies Inc executives and stock owners
Helius Medical Technologies Inc executives and other stock owners filed with the SEC include:
-
Jeffrey S. Mathiesen CPA, CPA,
CFO & Treasurer -
Dane Carl Andreeff,
Pres, CEO & Director -
Dr. Brian W. Bapty Ph.D.,
VP of Strategy and Bus. Devel. -
Dr. Antonella Favit-Van Pelt M.D., Ph.D.,
Chief Medical Officer -
Frederick Fantazzia,
VP of Sales & Marketing- North America -
Joyce N La Viscount,
CFO and COO -
Mitch E Tyler,
Director -
Edward M Straw,
-
Jonathan Sackier,
Chief Medical Officer -
Thomas E Griffin,
Director -
Huaizheng Peng,
Director -
Jennifer Laux,
Chief Commercial Officer -
Philippe Deschamps,
President and CEO -
Brian Bapty,
Vice President -
Pelt Antonella R. Favit Van,
Chief Medical Officer -
Paul Buckman,
-
Blane Walter,
-
Jeffrey S Mathiesen,
CFO and Treasurer -
Sherrie L Perkins,